2024 Southern Hemisphere Influenza Vaccine
Awarded Limited / Sole Source Justification Posted
- Solicitation number
- SPE2DP23R0003
- Agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- SPE2DP24D0003 Federal IDV award
- Awardee
- Sanofi Vaccines US Inc.
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Place of performance
- United States
Notice details come from SAM.gov. Updated .
About this opportunity
This Limited/Sole Source Justification Notice is from the Defense Logistics Agency Troop Support Medical and is for the procurement of the Southern Hemisphere Influenza Vaccine. The justification cites that Sanofi Pasteur Inc. is the only FDA-approved manufacturer for the Fluzone Quadrivalent Southern Hemisphere vaccine, for which the contract will provide a minimum of 6,000 packages containing 60,000 doses to a maximum of 6,600 packages containing 66,000 doses. Market research including a Sources Sought Notice did not identify any other potential sources able to meet the vaccine requirements. As such, the sole source award was granted to Sanofi Pasteur Inc. for this one-year firm fixed price indefinite quantity contract to supply the 2024 Southern Hemisphere influenza vaccine needs.
Notice text
Redacted J&A
Awarded contract SPE2DP24D0003 to unknown vendor for unknown amount on 2023-11-14.
Files
| File | Type | Posted |
|---|---|---|
| SH Flu 2024 J A Redacted.pdf |
Notice history
| Notice | Type | Posted |
|---|---|---|
| This notice | Limited / Sole Source Justification | |
| Influenza virus VAC | Award Notice | |
| 2024 Southern Hemisphere Influenza Vaccine | Solicitation | |
| 2024 Southern Hemisphere Influenza Vaccine | Pre-Solicitation | |
| 2024 Southern Hemisphere Influenza Vaccine | Pre-Solicitation |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity